Polymer Capital Management (Us) LLC Exelixis, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 11,821 shares of EXEL stock, worth $536,673. This represents 0.11% of its overall portfolio holdings.
Number of Shares
11,821Holding current value
$536,673% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
608Shares Held
256MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.52 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.3 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.02 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$673 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$535 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...